amifostine anhydrous has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grignani, G; Maiolo, A; Porta, C; Tua, A | 1 |
Davis, HD; Kumar, KS; Landauer, MR; Weiss, JF | 1 |
2 other study(ies) available for amifostine anhydrous and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Topics: Adenosine Diphosphate; Adult; Amifostine; Antioxidants; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; Nitric Oxide; Oxidative Stress; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Radiation-Protective Agents; Reactive Oxygen Species; Thromboxane B2 | 2000 |
Behavioral toxicity of selected radioprotectors.
Topics: 16,16-Dimethylprostaglandin E2; Adjuvants, Immunologic; Amifostine; Animals; Caffeine; Central Nervous System Stimulants; Cord Factors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucans; Interleukin-1; Leukotriene C4; Male; Mice; Motor Activity; Phospholipids; Platelet Activating Factor; Radiation-Protective Agents; Sulfhydryl Compounds | 1992 |